d-alpha tocopherol has been researched along with Bisphosphonate Osteonecrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreis, JD; Claudino, M; Delfrate, G; Fernandes, D; Franco, GCN; Lipinski, LC; Mecca, LEA; Mroczek, T | 1 |
| Janovszky, Á; Piffkó, J; Szabó, A; Vereb, T | 1 |
1 review(s) available for d-alpha tocopherol and Bisphosphonate Osteonecrosis
| Article | Year |
|---|---|
[Current approaches for early detection and treatment of medication-related osteonecrosis of jaw].
Topics: alpha-Tocopherol; Analgesics; Anti-Bacterial Agents; Biomarkers; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Debridement; Early Diagnosis; Humans; Laser Therapy; Low-Level Light Therapy; Ozone; Pentoxifylline; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Saliva; Severity of Illness Index; Teriparatide | 2014 |
1 other study(ies) available for d-alpha tocopherol and Bisphosphonate Osteonecrosis
| Article | Year |
|---|---|
Effect of pentoxifylline and α-tocopherol on medication-related osteonecrosis of the jaw in rats: Before and after dental extraction.
Topics: alpha-Tocopherol; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Osteonecrosis; Pentoxifylline; Rats; Rats, Wistar; Tooth Extraction | 2022 |